miller2, shealy

REVERSED

1600 Biotechnology and Organic Chemistry
1637 Ex Parte Gyllensten et al 10/529,447 SCHEINER 103(a) PORTER WRIGHT MORRIS & ARTHUR, LLP EXAMINER THOMAS, DAVID C

1700 Chemical & Materials Engineering
1733 Ex Parte Swidersky et al 11/453,922 GARRIS 103(a) CROWELL & MORING LLP EXAMINER KESSLER, CHRISTOPHER S

1787 Ex Parte Forloni et al 10/565,868 HASTINGS 102(b)/103(a) Sealed Air Corporation EXAMINER FREEMAN, JOHN D

2100 Computer Architecture and Software
2165 Ex Parte Cruanes et al 11/001,363 DIXON 102(e) HICKMAN PALERMO TRUONG & BECKER/ORACLE EXAMINER RADTKE, MARK A

2400 Networking, Mulitplexing, Cable, and Security
2431 Ex Parte Fischer et al 10/400247 DILLON 102(e)/103(a) KENYON & KENYON LLP EXAMINER SHERKAT, AREZOO

2800 Semiconductors, Electrical and Optical Systems and Components
2836 Ex Parte Reithofer 11/498,286 JEFFERY 102(b)/103(a) DICKE, BILLIG & CZAJA EXAMINER KAPLAN, HAL IRA

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3653 Ex Parte Johnson et al 11/622,897 ASTORINO 102(b)/103(a) WONG, CABELLO, LUTSCH, RUTHERFORD & BRUCCULERI, L.L.P. EXAMINER KUMAR, KALYANAVENKA K

3653 Ex Parte Vernon et al 10/699,485 McCARTHY 103(a) KNOBBE MARTENS OLSON & BEAR LLP EXAMINER MATTHEWS, TERRELL HOWARD
AFFIRMED-IN-PART

2400 Networking, Mulitplexing, Cable, and Security
2437 Ex Parte Blaker et al 09/852,562 POTHIER 102(e)/102(b)/103(a) 37 C.F.R. § 41.50(b) 101 COATS & BENNETT, PLLC EXAMINER CALLAHAN, PAUL E

Paper containing logic or a program is printed matter and is considered non-statutory under § 101. See In re Miller, 418 F.2d 1392, 1396 (CCPA 1969); see also Ex parte Shealy, 2007 WL 5211669, No. 2006-1601, at *21-22 (BPAI April 23, 2007) (informative) and Manual of Patent Examining Procedure (MPEP) § 706.03(a)(I)(A), 8th ed., Rev. 6, Sept. 2007.

Miller, In re, 418 F.2d 1392, 164 USPQ 46 (CCPA 1969) . . . . . . . . . . . . . . . . . . . . 706.03(a)

2453 Ex Parte Sen et al 10/245,476 BAUMEISTER 103(a) 103(a) WITHROW & TERRANOVA, P.L.L.C. EXAMINER NGUYEN, THU HA T
REEXAMINATION

EXAMINER AFFIRMED

3900 Central Reexamination Unit (CRU)
3745 Ex Parte 7384244 et al 90/009,815 COCKS 103(a) PATENT OWNER: TREGO, HINES & LADENHEIM, PLLC GENERAL ELECTRIC COMPANY THIRD PARTY REQUESTER: Mark F. Smith EXAMINER DOERRLER, WILLIAM CHARLES original EXAMINER WHITE, DWAYNE J
REISSUE

EXAMINER AFFIRMED

2800 Semiconductors, Electrical and Optical Systems and Components
2855 Ex Parte Budmiger 11/255,236 6,634,238 NAPPI 251 BACON & THOMAS, PLLC EXAMINER PATEL, HARSHAD R

We note that MPEP § 1414 (II)(C) states “[a]ny error in the claims must be identified by reference to the specific claim(s) and the specific claim language wherein lies the error.” MPEP § 1414(II)(C) also states “[a] statement of “. . . failure to include a claim directed to . . .” and then presenting a newly added claim, would not be considered [a] sufficient “error” statement because applicant has not pointed out what the other claims lacked that the newly added claim has, or vice versa. Such a statement would be no better than saying in the reissue oath or declaration that “this application is being filed to correct errors in the patent which may be noted from the change made by adding new claim 10. In both cases, the error has not been identified.”
AFFIRMED

1600 Biotechnology and Organic Chemistry
1612 Ex Parte Puri et al 12/200,211 FREDMAN 103(a) FISH & RICHARDSON P.C. (BO) EXAMINER SHOMER, ISAAC

1617 Ex Parte Glenn et al 11/973,591 FREDMAN 103(a) THE PROCTER & GAMBLE COMPANY EXAMINER BUCKLEY, AUDREA

1633 Ex Parte Zimenkov et al 11/063,223 WALSH 112(1) written description/112(1) enablement CERMAK NAKAJIMA LLP EXAMINER POPA, ILEANA

1700 Chemical & Materials Engineering
1726 Ex Parte Ogasawara et al 10/897,409 TIMM 103(a) KUBOVCIK & KUBOVCIK EXAMINER ANTHONY, JULIAN

1741 Ex Parte Park et al 11/260,585 McKELVEY 102(b)/103(a) 37 C.F.R. § 41.50(b) 103(a) HEWLETT-PACKARD COMPANY EXAMINER MINSKEY, JACOB T

2400 Networking, Mulitplexing, Cable, and Security
2427 Ex Parte Roye 10/690,674 DILLON 103(a) Walter J. Tencza Jr. EXAMINER RYAN, PATRICK A

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3694 Ex Parte Mirlas et al 10/286,921 KIM 101/103(a) IBM CORPORATION EXAMINER MILEF, ELDA G

diamond2, sterling, miller2, gulack, ngai

REVERSED

1600 Biotechnology and Organic Chemistry
1616 Ex Parte Slungaard et al 10/427,271 GRIMES 103(a) TAROLLI, SUNDHEIM, COVELL & TUMMINO L.L.P. EXAMINER SCHLIENTZ, NATHAN W

1641 Ex Parte Chandler et al 11/027,652 WALSH 103(a) DAFFER MCDANIEL LLP EXAMINER DO, PENSEE T
AFFIRMED-IN-PART

2100 Computer Architecture and Software
2111 Ex Parte Saha et al 11/392,381 BLANKENSHIP 103(a) TROP, PRUNER & HU, P.C. EXAMINER ZAMAN, FAISAL M
REEXAMINATION

REHEARING DENIED

3900 Central Reexamination Unit (CRU)
3673 MODEC INTERNATIONAL, LLC Requester and Respondent v. Patent of AKER KVAERNER ENGINEERING & TECHNOLOGY AS Patent Owner and Appellant 95/000,414 6,851,894 LEBOVITZ 103(a) WENDEROTH, LIND & PONACK, LLP FOR THIRD-PARTY REQUESTER: ANDREWS KURTH, LLP EXAMINER DAWSON, GLENN K original EXAMINER SAFAVI, MICHAEL

AFFIRMED

1600 Biotechnology and Organic Chemistry
1616 Ex Parte Latorse et al 10/553,363 WALSH 102(e)/103(a) 37 C.F.R. § 41.50(b) 103(a) OSTROLENK FABER GERB & SOFFEN EXAMINER PRYOR, ALTON NATHANIEL

See e.g., In re Diamond, 360 F.2d 214, 217 (CCPA 1966) (affirming obviousness where the evidence showed that synergy was expected because combined drugs targeted different cellular mechanisms, and no evidence to the contrary was produced).

1619 Ex Parte Bush 10/759,970 HASTINGS 103(a) MILES & STOCKBRIDGE PC MAGINOT, MOORE & BECK LLP EXAMINER TUROCY, DAVID P

1628 Ex Parte Rau 11/263,976 ADAMS 103(a)/obviousness-type double patenting 37 C.F.R. § 41.50(b) 103(a) Steven B. Kelber Berenato & White, LLC EXAMINER GEMBEH, SHIRLEY V

1657 Ex Parte Doyle et al 11/701,848 GREEN 102(b) JONES DAY EXAMINER GITOMER, RALPH J

1700 Chemical & Materials Engineering
1717 Ex Parte Bergeron 12/003,735 GREEN 102(b) MILES & STOCKBRIDGE PC EXAMINER JAGOE, DONNA A

1722 Ex Parte Lungu 11/296,902 TIMM 103(a) E I DU PONT DE NEMOURS AND COMPANY EXAMINER WALKE, AMANDA C

2184 Ex Parte Baugher et al 11/299,916 BLANKENSHIP 103(a) Chrysler Group LLC EXAMINER SNYDER, STEVEN G

3700 Mechanical Engineering, Manufacturing, and Products & Design
3716 Ex Parte Fiden et al 10/428,516 GREENHUT 103(a) NIXON PEABODY LLP EXAMINER
RADA, ALEX P

3728 Ex Parte Charng 10/887,911 SPAHN 102(b) BERENATO & WHITE, LLC EXAMINER BUI, LUAN KIM

[P]atentability cannot be predicated on printing alone. In re Sterling, 70 F.2d 910, 912 (CCPA 1934).

Printed matter can patentability distinguish a claimed invention from the prior art when the critical question of whether there exists any new and unobvious functional relationship between the claimed printed matter and the claimed substrate is answered in the affirmative. In re Miller, 418 F.2d 1392, 1396 (CCPA 1969); In re Gulack, 703 F.2d 1381, 1386 (Fed. Cir. 1983); and In re Ngai, 367 F.3d 1336, 1338 (Fed. Cir. 2004) (“The PTO has the better argument”).

Miller, In re, 418 F.2d 1392, 164 USPQ 46 (CCPA 1969) . . . . . . . . . . . . . . . . . . . . 706.03(a)

Gulack, In re, 703 F.2d 1381, 217 USPQ 401 (Fed. Cir. 1983) . . . . . . . . . . .2106.01, 2112.01

Ngai, In re, 367 F.3d 1336, 70 USPQ2d 1862 (Fed. Cir. 2004) . . . . . . . . . . 2106.01, 2112.01

NEW

REVERSED

1781 Ex Parte Ammann et al 10/564,452 GREEN 103(a) K&L Gates LLP EXAMINER GWARTNEY, ELIZABETH A

1765 Ex Parte Nguyen 11/732,389 TIMM 103(a) ROBERT A. KENT EXAMINER KUGEL, TIMOTHY J

AFFIRMED-IN-PART

1623 Ex Parte Bostrom et al 10/582,308 WALSH 102(b)/103(a) AKZO NOBEL INC. EXAMINER BLAND, LAYLA D

2628 Ex Parte Han et al 10/957,032 HAHN 102(a)/103(a) LEXMARK INTERNATIONAL, INC. EXAMINER RICHER, AARON M

3626 Ex Parte Logue 11/013,927 FISCHETTI 103(a) FOLEY AND LARDNER LLP EXAMINER
REYES, REGINALD R

AFFIRMED

3627 Ex Parte Ames et al 10/842,758 KIM 103(a) HEWLETT-PACKARD COMPANY EXAMINER HAIDER, FAWAAD

2492 Ex Parte Brabson et al 10/007,581 ZECHER 103(a) Cuenot, Forsythe & Kim, LLC EXAMINER PAN, JOSEPH T

3731 Ex Parte Kantor et al 10/827,819 CALVE 102(b)/103(a) MEDTRONIC VASCULAR, INC. EXAMINER SEVERSON, RYAN J

2444 Ex Parte Wilding et al 10/401,413 CHEN 102(e) IBM CORP (YA) EXAMINER BAYARD, DJENANE M